Earnings NYSE Nasdaq 100 U.S. Tech Politics AI Science SEC Business Wall Street Energy Bitcoin (BTC) Dow Jones Dividend NVIDIA (NVDA) Investing Markets Economy S&P 500 China World Donald Trump Fed Crude Oil Money Inflation Tesla (TSLA) Gold Software U.K. Entertainment Apple (AAPL) Health Amazon (AMZN) Retail Wealth Taxes Elon Musk Europe Real Estate Retirement Natural Gas 3M (MMM) Microsoft (MSFT) Security Meta Platforms (META) Current Canada Options Truist Financial Corp (TFC) Boeing (BA) Hedge Funds Jim Cramer Tax Insurance Google Sports Live Manufacturing Cars Pharmaceuticals Economics War Warren Buffett Ukraine Airlines Costco (COST) Mining Holidays Finance Japan York Silver Construction Interest Rates Goldman Sachs (GS) New York BlackRock (BLK) Walmart (WMT) Kamala Harris OpenAI ChatGPT Space Mortgage REITs Internet JPMorgan (JPM) Ethereum (ETH) Aerospace Enterprise Intel (INTC) Walt Disney (DIS) GBP USD Netflix (NFLX) India Texas IPOs Morgan Stanley (MS) AustraliaMore +
Stock Market News Stock Market News
  • Stocks
  • ETFs
  • Bonds
  • Commodities
  • Earnings
  • Dividends
  • REITs
  • IPOs
  • Cryptocurrency
  • Forex
  • Tech
  • Politics
  • +

2 weeks Gilead increases 2024 outlook, expects new drug filing by end of yearYahoo Finance

Gilead increases 2024 outlook, expects new drug filing by end of year.

Gilead (GILD)

X       

4 days Gilead Sciences, Inc. (GILD) Jefferies London Healthcare Conference (Transcript)Seeking Alpha X       

5 days Market Digest: ADTN, EQR, GILD, NFG, PRU, MSCIYahoo Finance X       

1 week Brokers Suggest Investing in Gilead (GILD): Read This Before Placing a BetZacks X       

2 weeks GILD or VRTX: Which Is the Better Value Stock Right Now?Zacks X       

2 weeks Gilead Beats on Q3 Earnings and Sales, Raises Annual OutlookZacks X       

2 weeks Why Gilead’s Solid Q3 Earnings Could Point To A Dividend Surprise Next YearSeeking Alpha X       

2 weeks Gilead Sciences (GILD) Q3 2024 Earnings Call TranscriptThe Motley Fool X       

2 weeks Gilead Sprints To A Profit-Taking Zone After Riding Covid Drug To Beat And RaiseInvestor's Business Daily X       

2 weeks Gilead’s third-quarter earnings beat by a wide margin, and biotech raises guidanceMarketWatch X       

3 weeks Gilead Science to Report Q3 Earnings: What’s in the Cards?Zacks X       

3 weeks Gilead Sciences (GILD) Gains As Market Dips: What You Should KnowZacks X       

4 weeks Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by New York State Teachers Retirement SystemMarketBeat X       

4 weeks Earnings Preview: Gilead Sciences (GILD) Q3 Earnings Expected to DeclineZacks X       

4 weeks Gilead Sciences (GILD) Stock Sinks As Market Gains: Here’s WhyZacks X       

4 weeks Gilead Sciences (NASDAQ:GILD) Given Sector Perform Rating at Royal Bank of CanadaMarketBeat X       

4 weeks Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Rating of “Moderate Buy” by BrokeragesMarketBeat X       

1 month Why Gilead Sciences (GILD) Dipped More Than Broader Market TodayZacks X       

1 month Gilead Sciences (NASDAQ:GILD) Sets New 12-Month High – Still a Buy?MarketBeat X       

1 month Gilead Sciences (NASDAQ:GILD) Stock Rating Upgraded by Leerink PartnrsMarketBeat X       

1 month Gilead, MRK Report Data From Investigational Combination Study for HIVZacks X       

1 month Calls of the Day: Gilead, Berkshire Hathaway and SLBYouTube X       

1 month Crew Capital Management Ltd. Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)MarketBeat X       

1 month Gilead Sciences (NASDAQ:GILD) Upgraded by Leerink Partners to OutperformMarketBeat X       

1 month Stratos Investment Management LLC Lowers Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)MarketBeat X       

1 month Goldman Sachs: Gilead Sciences, Inc. (NASDAQ:GILD) Is A Stock With High Consensus ROEInsider Monkey X       

More news +
Home | Contact
  • X

© 2024 The Stock Market News